Slovak company ZTS-ŠPECIÁL, in association with Excalibur Army and Kerametal, launched a new 120mm self-propelled mortar (SPM ...

In a report released today, Michael Ryskin from Bank of America Securities maintained a Buy rating on Zoetis (ZTS – Research Report). The ...

Buying $1000 In ZTS: If an investor had bought $1000 of ZTS stock 10 years ago, it would be worth $3,455.90 today based on a ...

Q4 2024 Earnings Call Transcript February 13, 2025 Zoetis Inc. beats earnings expectations. Reported EPS is $1.4, ...

We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where ...

In a report released today, Erin Wright from Morgan Stanley maintained a Buy rating on Zoetis (ZTS – Research Report), with a price target of ...

2025 Adjusted Diluted EPS Guidance: $6 to $6.10. Zoetis Inc (NYSE:ZTS) reported double-digit operational revenue growth of 11% for the full year 2024, driven by strong demand for its products.

Shares of animal health company Zoetis (NYSE:ZTS) fell 10.6% in the morning session after the company reported disappointing fourth-quarter results: its full-year EPS and revenue guidance fell ...

Below is Validea's guru fundamental report for ZOETIS INC (ZTS). Of the 22 guru strategies we follow, ZTS rates highest using our P/B Growth Investor model based on the published strategy of ...

Zoetis received a USDA conditional license for its H5N2 avian flu vaccine for chickens, marking a step in addressing the ...

Investment analysts at William Blair reduced their Q1 2025 EPS estimates for shares of Zoetis in a note issued to investors ...